Psychedelics, Technology and AI
A clear-eyed, multi-part look at how AI and modern technology are reshaping psychedelic therapy and clinical trials — written for the clinicians, researchers, operators, and builders doing the work.
Delivered by email, part by part, as each installment is released. Early subscribers get Part 1 first.
Three parts. One clear narrative.
Where the industry is → how technology changes it → where it is going.
The State of Psychedelic Medicine
Where the industry stands today: research, clinical adoption, regulation, care models, market development, and the barriers to scaling.
The Technology & AI Opportunity
The current technology gap, why conventional healthcare software falls short, and how AI can transform recruitment, screening, patient engagement, clinical workflows, research, compliance, and operations.
The Future of Psychedelic Care
What an AI-native psychedelic ecosystem could look like: connected data, intelligent automation, AI agents, personalized care, new operating models, and ultimately the emergence of the Psychedelic Operating System.
Written from inside the work
VistaraOS builds the AI-native operating system for psychedelic clinics and trials — so this report draws on what we see every day across patient care, trial operations, and compliance. Human clinicians in the loop, always.
Be first to read it
Leave your email and each part of the report lands in your inbox the moment it’s released.